Ann: Resignation of Dr Richard Mollard, page-46

I've been thinking about this too Deebo. I was wondering if Dr Mollard got overwhelmed with too much going on at the same time, too many concurrent responsibilities maybe. It this was the case and contributed to the reason for his resignation, the BoD may think it would just happen again if he was simply replaced. They maybe looking at something like "project leaders" for each of the trials, working together but each having their own distinct responsibilities depending on if it's MND, K9 cancer, human cancer or whatever. Maybe with Dr Aston back in Aus to oversee them and keep it all working? They seem to be doing this at Epichem with two new recent appointees.